GLOBAL BIODEFENSE – Soligenix, Inc. this week announced positive preliminary proof-of-concept results from its collaboration with University of Hawaiʻi at Mānoa (UH Mānoa) and Hawaii Biotech, Inc. (HBI) to develop a heat stable subunit Ebola vaccine. Continue reading